MARKET

NTEC

NTEC

Intec Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2900
+0.0149
+5.42%
After Hours: 0.2899 -0.0001 -0.03% 17:56 07/10 EDT
OPEN
0.2790
PREV CLOSE
0.2751
HIGH
0.3049
LOW
0.2716
VOLUME
2.74M
TURNOVER
--
52 WEEK HIGH
4.365
52 WEEK LOW
0.1324
MARKET CAP
20.09M
P/E (TTM)
-0.7047
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NTEC stock price target is 0.2250 with a high estimate of 0.2500 and a low estimate of 0.2000.

EPS

NTEC News

More
35 Stocks Moving in Monday's Pre-Market Session
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares rose 88.2% to $2.39 in pre-market trading after declining over 5% on Thursday.
Benzinga · 4d ago
Top Marijuana Stocks on the NASDAQ for July 2020
The marijuana industry includes companies directly related to the research, development, and distribution of cannabis products, as well as companies that indirectly support these operations. As a growing number of U.S. states and countries around the world le
Investopedia · 06/30 18:07
Intec Pharma (NASDAQ:NTEC) Will Have To Spend Its Cash Wisely
Simply Wall St. · 06/13 14:04
Cannabis Stock Gainers And Losers From June 5, 2020
Gainers Grindrod Shipping Hldgs (NASDAQ: GRIN) shares closed up 19.18% at $2.92 Choom Holdings (OTC: CHOOF) shares closed up 14.66% at $0.15
Benzinga · 06/05 21:00
Intec Pharma Ltd. (NTEC) Upgraded to Strong Buy: Here's Why
Intec Pharma Ltd. (NTEC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Zacks · 06/05 16:00
Implied Volatility Surging for Intec Pharma (NTEC) Stock Options
Zacks · 06/02 15:03
Top Marijuana Stocks on the NASDAQ for June 2020
These are the NASDAQ-listed marijuana stocks with the best value, fastest growth, and most momentum for June.
Investopedia · 05/28 15:38
Intec Pharma to Present at Jefferies Virtual Healthcare Conference
PR Newswire · 05/28 13:00

Industry

Biotechnology & Medical Research
-0.77%
Pharmaceuticals & Medical Research
-0.48%

Hot Stocks

Symbol
Price
%Change

About NTEC

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.
More

Webull offers kinds of Intec Pharma Ltd stock information, including NASDAQ:NTEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTEC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTEC stock methods without spending real money on the virtual paper trading platform.